Phase
Condition
N/ATreatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
ADPKD patients ≥18 years old at the time of tolvaptan initiation
The treating physician must have reached the decision to treat the patient withJINARC™ (tolvaptan) as per the Canadian Product Monograph prior to and independentlyof soliciting the patient to participate in the study
The patient or legal guardian must have signed an informed consent indicating theunderstanding of the study and allowing the use of their anonymous data for thepurposes of the study
Exclusion
Exclusion Criteria:
The patient does not comprehend or refuses to sign the informed consent
The patient has any contraindications to the use of JINARC™ (tolvaptan) as specifiedin the Canadian Product Monograph
The patient has any condition which, as per the judgment of the treating physician,prohibits them from participating in the study
Study Design
Connect with a study center
empty
Calgary, Alberta
CanadaSite Not Available
Edmonton, Alberta
CanadaActive - Recruiting
empty
Moncton, New Brunswick
CanadaSite Not Available
empty
Saint John, New Brunswick
CanadaSite Not Available
empty
Halifax, Nova Scotia
CanadaSite Not Available
empty
Sydney, Nova Scotia
CanadaSite Not Available
empty
Brampton, Ontario
CanadaSite Not Available
London, Ontario
CanadaActive - Recruiting
empty
Mississauga, Ontario
CanadaSite Not Available
empty
Oakville, Ontario
CanadaSite Not Available
Ottawa, Ontario
CanadaActive - Recruiting
empty
Richmond Hill, Ontario
CanadaSite Not Available
empty
Scarborough, Ontario
CanadaSite Not Available
Toronto, Ontario
CanadaActive - Recruiting
empty
Greenfield Park, Quebec
CanadaSite Not Available
Montreal, Quebec
CanadaActive - Recruiting
Quebec City, Quebec
CanadaActive - Recruiting
empty
Rimouski, Quebec
CanadaSite Not Available
empty
Saskatoon, Saskatchewan
CanadaSite Not Available
empty
Quebec,
CanadaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.